Annual Report

Overview

The report records a 6.1% year-on-year revenue decline to HK$1,513.4 million in 2025, while the Group employed 780 people. It also reports 66 authorized patents and continued overseas expansion, including new retail and experience locations. The report describes sustained investment in Chinese medicine research, product development, public welfare and international brand promotion.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services